Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01410864 · ClinicalTrials.gov registry record
DuraSeal Exact Spine Sealant System Post-Approval Study
A clinical trial of Dural Sealing, sponsored by Integra LifeSciences Corporation.
- Completed
- Registry status
- 924
- Enrollment target
- 20
- Study locations
NCT01410864: Completed study of Dural Sealing, sponsored by Integra LifeSciences Corporation.
NCT01410864 is a study of Dural Sealing that has completed, run by Integra LifeSciences Corporation. The registered enrollment target is 924 participants. The trial reports 20 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01410864, a study of Dural Sealing, has completed, sponsored by Integra LifeSciences Corporation.
- COMPLETED
- Registry status
- 924 participants
- Enrollment target
- 20
- Study locations
Study Summary
This is a non-randomized, post-approval study to further evaluate the rate of post-operative Cerebral Spinal Fluid (CSF) leaks in subjects who undergo a spinal procedure and receive DuraSeal Exact Spine Sealant System.
Conditions Studied
Interventions
- OTHER Control
- DEVICE DuraSeal Exact Spine Sealant System
Study Locations (20)
California
- - Los Angeles
- - Sacramento
- - San Francisco
- - San Jose
- - Stanford
Colorado
- - Boulder
- - Colorado Springs
- - Denver
Florida
- - Tampa
- - Tampa
Arizona
- - Phoenix
District of Columbia
- - Washington D.C.
Georgia
- - Atlanta
Illinois
- - Chicago
Kansas
- - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 924 participants |
| Start Date | 2011-08 |
| Est. Completion | 2016-07 |
What the finished NCT01410864 record still lists
NCT01410864 is an observational study that tracks outcomes without assigning an intervention. The registered 924 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Dural Sealing appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.
NCT01410864 names 20 study sites across 13 states, led by California, Colorado, Florida.
Frequently Asked Questions
What is clinical trial NCT01410864 about?
NCT01410864 is a clinical study titled "DuraSeal Exact Spine Sealant System Post-Approval Study". This is a non-randomized, post-approval study to further evaluate the rate of post-operative Cerebral Spinal Fluid (CSF) leaks in subjects who undergo a spinal procedure and receive DuraSeal Exact Spine Sealant System.
What is the current status of trial NCT01410864?
This trial is currently completed. The enrollment target is 924 participants. The study started on 2011-08. Estimated completion is 2016-07.
What conditions does trial NCT01410864 study?
This clinical trial studies the following conditions: Dural Sealing.
What interventions are being tested in trial NCT01410864?
The interventions under investigation include: Control (OTHER), DuraSeal Exact Spine Sealant System (DEVICE).
Who is sponsoring clinical trial NCT01410864?
This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01410864 being conducted?
This trial has 20 study locations across Arizona, California, Colorado, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04692493 · 924 participants · Phase 3
Ra-pro Pragmatic Trial
- NCT05656807 · 924 participants · NA
Evaluation of Child Care Staff Weight Management Program
- NCT06082453 · 924 participants · NA
Modernizing Perinatal Syphilis Testing
- NCT03995082 · 925 participants · NA
Breast Cancer Patient Engagement With Patient Reported Outcome Measure Survey
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia